Efficacy of Topical Tapinarof Versus Betamethasone in the Treatment of Plaque Psoriasis (NCT07635043) | Clinical Trial Compass
Not Yet RecruitingPhase 4
Efficacy of Topical Tapinarof Versus Betamethasone in the Treatment of Plaque Psoriasis
Pakistan120 participantsStarted 2026-08-01
Plain-language summary
To assess the effectiveness of topical tapinarof to topical betamethasone in patients with mild to moderate plaque psoriasis presenting to tertiary care hospital in Islamabad
Who can participate
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age 18 years-65 years
* Clinically diagnosed plaque psoriasis involving body surface area ( BSA) of 2-20% (mild to moderate severity)
* Disease duration of at least 6 months
* Willing and able to provide written informed consent
* Not currently using any other topical and systematic psoriasis therapy, or willing to undergo a washout period (2 weeks for topical therapies)
Exclusion Criteria:
* Severe psoriasis (BSA \>20% or requiring systemic therapy)
* Pregnant and lactating mothers
* Known hypersensitivity to Tapinarof or any of its excipients
* Concurrent dermatological conditions that may interfere with assessment e.g fungal infections,atopic dermatitis
* Use of systemic immunosuppressants (methotrexate, cyclosporine, biologics ) or phototherapy within 4 weeks before enrollment
* History of malignancy or current active infection
* Known hypersensitivity to betamethasone or Tapinarof
* Use of powerful topical corticosteroids within two weeks previously
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Percentage of participants achieving a 75% reduction from baseline in psoriasis area and severity index(PASI 75)